JensonR+ achieve first IMP Batch Release

We’re pleased to announce that our team at JensonR+ have released our first Investigational Medicinal Products (IMP) batch.

Our quality team have made the final sign-off marking the culmination of the quality process through which a batch of IMP has been shown to conform to all aspects of Good Manufacturing Practice (GMP).

JensonR+ Director Paul Quinn witnessing QP Darren Daly signing the batch register

“It is so exciting to be part of such a dynamic team that is making such a difference to patients. I want to thank our QP Darren Daly and Quality Officer Caterina Cioffi for their professionalism and dedication over all the months of work that has gone into getting to this release.

Also thanks to Head of Quality June Gacquin who has done amazing work in managing and coordinating the project.

We really appreciate every one of our team for playing their part, be it in setting up SOP’s, processes, arranging flights for audits, to support IMP’s – this really was teamwork at its best.

It is an amazing achievement for JensonR+ and something that we are all very proud of.”

Paul Quinn, Director JensonR+

 If you would like to discuss how the expert team at JensonR+ can provide support at all levels, from strategy through to administration, then please do not hesitate to contact us at consultancy@jensongroup.com.

Latest posts by Paul Quinn (see all)